Roopa Industries — 360° view

Roopa Industries, a company in the Pharmaceuticals industry, reported revenue of ₹33 crore and net profit of ₹0.33 crore for the June 2026 quarter.

Roopa Industries (BSE: ROOPAIND) closed at ₹42.25 on 20 Nov 2026, down 15.8% over the past year. Its market capitalisation is ₹33 crore and it trades at 8.1 times earnings.

Share price
₹42.25 (20 Nov 2026)
Market cap
₹33 Cr (20 Nov 2026)
P/E
8.06 (20 Nov 2026)
Revenue
₹33 Cr (June 2026 quarter)
Net profit
₹0 Cr (June 2026 quarter)
ROCE
15.0% (FY26)
ROE
23.8% (FY26)
Book value
₹22.4 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹63.40 / ₹38.10 (20 Nov 2026)
1-year return
-15.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: ROOPAIND

Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.